Clark Drug Company, Llc

Clark Drug Company, Llc ( CLARK DRUG COMPANY, LLC ) is A Pharmacy Provider in Caledonia, MS. The NPI Number for Clark Drug Company, Llc is 1013294461.

The current location address for Clark Drug Company, Llc is 741 MAIN ST Caledonia, MS 39740 and the contact number is 6623564000 and fax number is 6623564044. The mailing address for Clark Drug Company, Llc is PO BOX 478 Caledonia, MS 39740- 6623564000 (mailing address contact number - 6623564000).

A pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.

What is the NPI Number for Clark Drug Company, Llc ?

Answer: The NPI Number for Clark Drug Company, Llc is 1013294461

Where is Clark Drug Company, Llc located?

Answer: Clark Drug Company, Llc is located at 741 MAIN ST Caledonia, MS 39740.

What is the specialty for Clark Drug Company, Llc ?

Answer: The Specialty of Clark Drug Company, Llc is A Pharmacy Provider.

Are there any online reviews for Clark Drug Company, Llc ?

Answer: Not yet!

Are there any other health care providers in Caledonia, MS?

Answer: Yes, there are given below...

Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Clark Drug Company, Llc

Number of HCPCS	15
Number of Medicare Beneficiaries	244
Number of Services	417
Total Submitted Charge Amount	19072.08
Total Medicare Allowed Amount	13564.75
Total Medicare Payment Amount	13564.75
Total Medicare Standardized Payment Amount	14593.75
Drug Suppress Indicator
Number of HCPCS Associated With Drug Services	4
Number of Medicare Beneficiaries With Drug Services	31
Number of Drug Services	34
Total Drug Submitted Charge Amount	2350.19
Total Drug Medicare Allowed Amount	2350.19
Total Drug Medicare Payment Amount	2350.19
Total Drug Medicare Standardized Payment Amount	2303.05
Medical Suppress Indicator
Number of HCPCS Associated With Medical Services	11
Number of Medicare Beneficiaries With Medical	244
Number of Medical Services	383
Total Medical Submitted Charge Amount	16721.89
Total Medical Medicare Allowed Amount	11214.56
Total Medical Medicare Payment Amount	11214.56
Total Medical Medicare Standardized Payment Amount	12290.7
Average Age of Beneficiaries	71
Number of Beneficiaries Age Less 65	41
Number of Beneficiaries Age 65 to 74	121
Number of Beneficiaries Age 75 to 84	67
Number of Beneficiaries Age Greater 84	15
Number of Female Beneficiaries	125
Number of Male Beneficiaries	119
Number of Non-Hispanic White Beneficiaries	199
Number of Black or African American Beneficiaries
Number of Asian Pacific Islander Beneficiaries
Number of Hispanic Beneficiaries
Number of American Indian/Alaska Native Beneficiaries
Number of Beneficiaries With Race Not Elsewhere Classified
Number of Beneficiaries With Medicare & Medicaid Entitlement	47
Number of Beneficiaries With Medicare Only Entitlement	197
Percent (%) of Beneficiaries Identified With Atrial Fibrillation
Percent (%) of Beneficiaries Identified With Alzheimer's Disease or Dementia	0.05
Percent (%) of Beneficiaries Identified With Asthma
Percent (%) of Beneficiaries Identified With Cancer	0.05
Percent (%) of Beneficiaries Identified With Heart Failure	0.11
Percent (%) of Beneficiaries Identified With Chronic Kidney Disease	0.22
Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease	0.09
Percent (%) of Beneficiaries Identified With Depression	0.14
Percent (%) of Beneficiaries Identified With Diabetes	0.28
Percent (%) of Beneficiaries Identified With Hyperlipidemia	0.43
Percent (%) of Beneficiaries Identified With Hypertension	0.56
Percent (%) of Beneficiaries Identified With Ischemic Heart Disease	0.31
Percent (%) of Beneficiaries Identified With Osteoporosis
Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis	0.32
Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders
Percent (%) of Beneficiaries Identified With Stroke
Average HCC Risk Score of Beneficiaries	0.9664